Healthcare utilization, costs, and epidemiology of Huntington's disease in Israel.

ABSTRACT:

Introduction

Data on Huntington's disease (HD) epidemiology, treatment patterns, and economic burden in Israel are scarce.

Methods

Annual prevalence and incidence of HD (ICD-9-CM 333.4) were assessed in the Israel-based Maccabi Healthcare Services (MHS) database 2016-2018. Adherence (medication possession rate [MPR], proportion of disease covered) were assessed for adult people with HD (PwHD) 2013-2018. Healthcare resources utilization (HCRU) and costs related to inpatient and outpatient visits and all medications in 2018 were assessed for PwHD, who were randomly matched to MHS members without HD (1:3) by birth-year and sex.

Results

Overall, 164 patients had at least one HD diagnosis. Annual prevalence and incidence were 4.45 and 0.24/100,000, respectively. A total of

SUBMITTER: Barer Y 

PROVIDER: S-EPMC10366633 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature